Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Evaluation of an in vivo pulmonary aspergillosis model for triazole susceptibility breakpoint development.
Journal: Antimicrobial agents and chemotherapy
Published: January 30, 2026
An Executed Plan to Combat COVID-19 in the United States.
Journal: Advances in anesthesia
Published: November 04, 2022
AZD1222-induced nasal antibody responses are shaped by prior SARS-CoV-2 infection and correlate with virologic outcomes in breakthrough infection.
Journal: Cell reports. Medicine
Published: July 13, 2022
Anti-SARS-CoV-2 IgG and IgA antibodies in COVID-19 convalescent plasma do not facilitate antibody-dependent enhance of viral infection.
Journal: bioRxiv : the preprint server for biology
Published: September 21, 2021
Donor Anti-Spike Immunity is Related to Recipient Recovery and Can Predict the Efficacy of Convalescent Plasma Units.
Journal: medRxiv : the preprint server for health sciences
Published: March 10, 2021
Use of convalescent plasma in COVID-19 patients with immunosuppression.
Journal: Transfusion
Published: February 19, 2021
The Effect of Convalescent Plasma Therapy on COVID-19 Patient Mortality: Systematic Review and Meta-analysis.
Journal: medRxiv : the preprint server for health sciences
Published: November 03, 2020
The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysis.
Journal: Mayo Clinic proceedings
Published: October 28, 2020
Hospitalized COVID-19 Patients treated with Convalescent Plasma in a Mid-size City in the Midwest.
Journal: Research square
Published: August 15, 2020
Hospitalized COVID-19 patients treated with convalescent plasma in a mid-size city in the Midwest.
Journal: Translational medicine communications
Published: August 04, 2020
Last Updated: 09/26/2026